Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,044 | -23,739 | -21,743 | -17,382 | -4,324 |
| Depreciation Amortization | 24 | 108 | 81 | 53 | 26 |
| Accounts payable and accrued liabilities | -397 | 69 | -140 | -301 | -440 |
| Other Working Capital | -324 | -3,058 | -1,509 | -983 | -290 |
| Other Operating Activity | 285 | 9,951 | 9,524 | 9,145 | 272 |
| Operating Cash Flow | $-2,456 | $-16,669 | $-13,787 | $-9,468 | $-4,756 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -35 | -35 | -16 | N/A |
| Investing Cash Flow | $N/A | $-35 | $-35 | $-16 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,507 | 1,492 | 1,458 | 1,401 |
| Debt Repayment | -49 | -70 | -69 | -67 | -56 |
| Common Stock Issued | 2,303 | 17,469 | 6,973 | 6,694 | N/A |
| Other Financing Activity | 1,612 | -713 | 1,339 | 1,798 | 1,727 |
| Financing Cash Flow | $3,866 | $18,193 | $9,735 | $9,883 | $3,072 |
| Exchange Rate Effect | -36 | -92 | -44 | 62 | 93 |
| Beginning Cash Position | 13,102 | 11,705 | 11,705 | 11,705 | 11,705 |
| End Cash Position | 14,476 | 13,102 | 7,574 | 12,166 | 10,114 |
| Net Cash Flow | $1,374 | $1,397 | $-4,131 | $461 | $-1,591 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,456 | -16,669 | -13,787 | -9,468 | -4,756 |
| Capital Expenditure | N/A | -35 | -35 | -16 | N/A |
| Free Cash Flow | -2,456 | -16,704 | -13,822 | -9,484 | -4,756 |